Andrea Hahn, MD, is an Attending in Infectious Diseases and K12 Scholar in the Omics of Lung Disease at Children's National Medical Center in Washington, DC. She completed her pediatric residency at Nationwide Children's Hospital in Columbus, OH in 2011 and her infectious disease and clinical pharmacology fellowships at Cincinnati Children's Hospital Medical Center in 2014. Dr. Hahn is board certified in Pediatrics, Pediatric Infectious Diseases, and Clinical Pharmacology. She was awarded an NIH T32 training grant in Pediatric Clinical Pharmacology from 2012-2014, as well as an NIH K12 training grant in the Omics of Lung Disease in Children from 2014-2017. She has also receiving research funding from the NIH Loan Repayment Program, the Clark Charitable Trust, and the Margaret Q. Landenberger Foundation. She brings expertise in pharmacokinetic modeling of antimicrobials to Children's National, and is currently investigating the impact of sub-therapeutic beta-lactam antibiotics on the airway microbiome in children with cystic fibrosis.